- Home
- LXEO vs CLW Comparison
LXEO vs CLW Comparison
Compare LXEO & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXEO | CLW |
|---|---|---|
| Founded | 2017 | 1926 |
| Country | United States | United States |
| Employees | N/A | 3710 |
| Industry | | Paper |
| Sector | | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.7M | 338.7M |
| IPO Year | 2023 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LXEO | CLW |
|---|---|---|
| Price | $3.56 | $19.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $20.30 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 1.2M | 102.2K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $654,000.00 | ★ $1,555,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.42 |
| 52 Week Low | $2.98 | $11.73 |
| 52 Week High | $10.99 | $23.59 |
Technical Indicators
Market Signals| Indicator | LXEO | CLW |
|---|---|---|
| Relative Strength Index (RSI) | 29.79 | 41.62 |
| Support Level | N/A | $19.25 |
| Resistance Level | $5.38 | $20.80 |
| Average True Range (ATR) | 0.26 | 0.83 |
| MACD | -0.07 | -0.22 |
| Stochastic Oscillator | 27.86 | 15.17 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.